As of 29 February 2012, Ontario passed legislation delisting oxycodone from the province's community drug advantage program. This was a primary for almost any province to delist a drug depending on addictive properties. The new regulation prohibits prescriptions for OxyNeo besides to certain patients beneath the Outstanding Entry Plan together with